Here we investigated metabolic rhythms in HepG2 cells, a human hepatocellular carcinoma–derived cell line, and the link between these rhythms and the circadian clock in control (Bmal1-wildtype) and Bmal1-disrupted (B-D) cells having their molecular clock impaired. The gene discussed is CLOCK; the disease is hepatocellular carcinoma.